IQVIA Holdings Inc. reports developments tied to its role as a global provider of clinical research services, commercial insights and healthcare intelligence for life sciences and healthcare customers. Company news commonly covers quarterly results for R&D Solutions and Commercial Solutions, contracted clinical-development activity, earnings guidance and management presentations at healthcare conferences.
Updates also include capital actions such as common-stock repurchase authorizations and technology announcements involving IQVIA Connected Intelligence™, Healthcare-grade AI® and IQVIA.ai, a unified agentic AI platform for clinical, commercial and real-world domains.
IQVIA Holdings Inc. (NYSE: IQV) will release its third-quarter financial results on October 20, 2020, before the market opens. Management will host a conference call at 9:00 a.m. ET on the same day, which can be accessed via the IQVIA Investor Relations website. Registration is required for participation, and a replay will be available shortly after the event. IQVIA specializes in analytics and technology solutions for the life sciences sector, employing around 67,000 individuals globally.